BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 31365319)

  • 41. Postsymptomatic restoration of SMN rescues the disease phenotype in a mouse model of severe spinal muscular atrophy.
    Lutz CM; Kariya S; Patruni S; Osborne MA; Liu D; Henderson CE; Li DK; Pellizzoni L; Rojas J; Valenzuela DM; Murphy AJ; Winberg ML; Monani UR
    J Clin Invest; 2011 Aug; 121(8):3029-41. PubMed ID: 21785219
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation of Survival Motor Neuron Protein by the Nuclear Factor-Kappa B Pathway in Mouse Spinal Cord Motoneurons.
    Arumugam S; Mincheva-Tasheva S; Periyakaruppiah A; de la Fuente S; Soler RM; Garcera A
    Mol Neurobiol; 2018 Jun; 55(6):5019-5030. PubMed ID: 28808928
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Muscle-specific SMN reduction reveals motor neuron-independent disease in spinal muscular atrophy models.
    Kim JK; Jha NN; Feng Z; Faleiro MR; Chiriboga CA; Wei-Lapierre L; Dirksen RT; Ko CP; Monani UR
    J Clin Invest; 2020 Mar; 130(3):1271-1287. PubMed ID: 32039917
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vivo NMDA receptor activation accelerates motor unit maturation, protects spinal motor neurons, and enhances SMN2 gene expression in severe spinal muscular atrophy mice.
    Biondi O; Branchu J; Sanchez G; Lancelin C; Deforges S; Lopes P; Pariset C; Lécolle S; Côté J; Chanoine C; Charbonnier F
    J Neurosci; 2010 Aug; 30(34):11288-99. PubMed ID: 20739549
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Selective Neuromuscular Denervation in Taiwanese Severe SMA Mouse Can Be Reversed by Morpholino Antisense Oligonucleotides.
    Lin TL; Chen TH; Hsu YY; Cheng YH; Juang BT; Jong YJ
    PLoS One; 2016; 11(4):e0154723. PubMed ID: 27124114
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Motor neuron rescue in spinal muscular atrophy mice demonstrates that sensory-motor defects are a consequence, not a cause, of motor neuron dysfunction.
    Gogliotti RG; Quinlan KA; Barlow CB; Heier CR; Heckman CJ; Didonato CJ
    J Neurosci; 2012 Mar; 32(11):3818-29. PubMed ID: 22423102
    [TBL] [Abstract][Full Text] [Related]  

  • 47. AAV9-Stathmin1 gene delivery improves disease phenotype in an intermediate mouse model of spinal muscular atrophy.
    Villalón E; Kline RA; Smith CE; Lorson ZC; Osman EY; O'Day S; Murray LM; Lorson CL
    Hum Mol Genet; 2019 Nov; 28(22):3742-3754. PubMed ID: 31363739
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proteomic assessment of a cell model of spinal muscular atrophy.
    Wu CY; Whye D; Glazewski L; Choe L; Kerr D; Lee KH; Mason RW; Wang W
    BMC Neurosci; 2011 Mar; 12():25. PubMed ID: 21385431
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Spinal Muscular Atrophy: More than a Disease of Motor Neurons?
    Nash LA; Burns JK; Chardon JW; Kothary R; Parks RJ
    Curr Mol Med; 2016; 16(9):779-792. PubMed ID: 27894243
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Temporal and tissue-specific variability of SMN protein levels in mouse models of spinal muscular atrophy.
    Groen EJN; Perenthaler E; Courtney NL; Jordan CY; Shorrock HK; van der Hoorn D; Huang YT; Murray LM; Viero G; Gillingwater TH
    Hum Mol Genet; 2018 Aug; 27(16):2851-2862. PubMed ID: 29790918
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stasimon Contributes to the Loss of Sensory Synapses and Motor Neuron Death in a Mouse Model of Spinal Muscular Atrophy.
    Simon CM; Van Alstyne M; Lotti F; Bianchetti E; Tisdale S; Watterson DM; Mentis GZ; Pellizzoni L
    Cell Rep; 2019 Dec; 29(12):3885-3901.e5. PubMed ID: 31851921
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nerve sprouting capacity in a pharmacologically induced mouse model of spinal muscular atrophy.
    Rimer M; Seaberg BL; Yen PF; Lam S; Hastings RL; Lee YI; Thompson WJ; Feng Z; Metzger F; Paushkin S; Ko CP
    Sci Rep; 2019 May; 9(1):7799. PubMed ID: 31127156
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Calpain system is altered in survival motor neuron-reduced cells from in vitro and in vivo spinal muscular atrophy models.
    de la Fuente S; Sansa A; Hidalgo I; Vivancos N; Romero-Guevara R; Garcera A; Soler RM
    Cell Death Dis; 2020 Jun; 11(6):487. PubMed ID: 32587237
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Abnormal mitochondrial transport and morphology as early pathological changes in human models of spinal muscular atrophy.
    Xu CC; Denton KR; Wang ZB; Zhang X; Li XJ
    Dis Model Mech; 2016 Jan; 9(1):39-49. PubMed ID: 26586529
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy.
    Riessland M; Ackermann B; Förster A; Jakubik M; Hauke J; Garbes L; Fritzsche I; Mende Y; Blumcke I; Hahnen E; Wirth B
    Hum Mol Genet; 2010 Apr; 19(8):1492-506. PubMed ID: 20097677
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Skeletal muscle DNA damage precedes spinal motor neuron DNA damage in a mouse model of Spinal Muscular Atrophy (SMA).
    Fayzullina S; Martin LJ
    PLoS One; 2014; 9(3):e93329. PubMed ID: 24667816
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy.
    Murray LM; Comley LH; Thomson D; Parkinson N; Talbot K; Gillingwater TH
    Hum Mol Genet; 2008 Apr; 17(7):949-62. PubMed ID: 18065780
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Motor unit loss estimation by the multipoint incremental MUNE method in children with spinal muscular atrophy--a preliminary study.
    Gawel M; Kostera-Pruszczyk A; Lusakowska A; Jedrzejowska M; Ryniewicz B; Lipowska M; Gawel D; Kaminska A
    Neuromuscul Disord; 2015 Mar; 25(3):216-21. PubMed ID: 25500012
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy.
    Passini MA; Bu J; Roskelley EM; Richards AM; Sardi SP; O'Riordan CR; Klinger KW; Shihabuddin LS; Cheng SH
    J Clin Invest; 2010 Apr; 120(4):1253-64. PubMed ID: 20234094
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chronic Pharmacological Increase of Neuronal Activity Improves Sensory-Motor Dysfunction in Spinal Muscular Atrophy Mice.
    Simon CM; Blanco-Redondo B; Buettner JM; Pagiazitis JG; Fletcher EV; Sime Longang JK; Mentis GZ
    J Neurosci; 2021 Jan; 41(2):376-389. PubMed ID: 33219005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.